20n Bio Raises $3.3 Million in Series Seed Funding to Advance Computational Design of New Proteins for Therapeutics
MALVERN, PA — 20n Bio announced it raised a $3.3 million seed round led by BlueRun Ventures China. 20n Bio will use the proceeds from the financing to expand its …
Read More